NCT02371941View on ClinicalTrials.gov

Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

December 31, 2017

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

oral cromolyn sodium

Oral cromolyn sodium

DRUG

Placebo

Saline

Trial Locations (1)

38105

LeBonheur Children's Hospital, Memphis

All Listed Sponsors
lead

University of Tennessee

OTHER

NCT02371941 - Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis | Biotech Hunter | Biotech Hunter